{"transactions":[{"id":4624179,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-09-18T20:41:57.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":193957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":193957,"derivative":{"underlying":"Common Stock","underlying_shares":193957},"source":{"system":"sec-edgar","filing":"0001995275-26-000018","document":"form4a-09182026_080949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000018/form4a-09182026_080949.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4624178,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2026-09-18T20:41:57.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":193957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":193957,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":193957},"source":{"system":"sec-edgar","filing":"0001995275-26-000018","document":"form4a-09182026_080949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000018/form4a-09182026_080949.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4618680,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-09-15T23:07:59.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":193957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":193957,"derivative":{"underlying":"Common Stock","underlying_shares":193957},"source":{"system":"sec-edgar","filing":"0001995275-26-000016","document":"form4-09152026_110953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995275/000199527526000016/form4-09152026_110953.xml","form_type":"4"}},{"id":4618679,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2026-09-15T23:07:59.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":193957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":193957,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":193957},"source":{"system":"sec-edgar","filing":"0001995275-26-000016","document":"form4-09152026_110953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995275/000199527526000016/form4-09152026_110953.xml","form_type":"4"}},{"id":774805,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-05-18T20:03:41.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":51021,"price":3.92,"value":200002.32,"ownership":{"direct":true},"balance_after":569643,"source":{"system":"sec-edgar","filing":"0001995275-26-000014","document":"form4-05182026_080535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000014/form4-05182026_080535.xml","form_type":"4"}},{"id":810275,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-10T22:46:06.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":14500,"price":3.38,"value":49010.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":518622,"source":{"system":"sec-edgar","filing":"0001995275-26-000012","document":"form4-04102026_100459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000012/form4-04102026_100459.xml","form_type":"4"}},{"id":812429,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-09T00:32:58.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":63945,"price":3.4,"value":217413.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":533122,"source":{"system":"sec-edgar","filing":"0001995275-26-000008","document":"form4-04092026_120451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000008/form4-04092026_120451.xml","form_type":"4"}},{"id":812428,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-09T00:32:58.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":94087,"price":3.43,"value":322718.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":597067,"source":{"system":"sec-edgar","filing":"0001995275-26-000008","document":"form4-04092026_120451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000008/form4-04092026_120451.xml","form_type":"4"}},{"id":812427,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-09T00:32:58.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":102395,"price":3.51,"value":359406.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":691154,"source":{"system":"sec-edgar","filing":"0001995275-26-000008","document":"form4-04092026_120451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000008/form4-04092026_120451.xml","form_type":"4"}},{"id":816107,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-03T22:17:15.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":831148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2026."}],"balance_after":831148,"derivative":{"exercise_price":3.54,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":831148},"source":{"system":"sec-edgar","filing":"0001995275-26-000006","document":"form4-04032026_100411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000006/form4-04032026_100411.xml","form_type":"4"}},{"id":816106,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T22:17:15.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":775828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":775828},"source":{"system":"sec-edgar","filing":"0001995275-26-000006","document":"form4-04032026_100411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000006/form4-04032026_100411.xml","form_type":"4"}},{"id":816105,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T22:17:15.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":26858,"price":3.48,"value":93465.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":793549,"source":{"system":"sec-edgar","filing":"0001995275-26-000006","document":"form4-04032026_100411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000006/form4-04032026_100411.xml","form_type":"4"}},{"id":816104,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T22:17:15.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":775828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."}],"balance_after":820407,"source":{"system":"sec-edgar","filing":"0001995275-26-000006","document":"form4-04032026_100411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000006/form4-04032026_100411.xml","form_type":"4"}},{"id":850805,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T23:36:53.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":32500,"derivative":{"underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001995275-26-000002","document":"form4-03102026_110350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000002/form4-03102026_110350.xml","form_type":"4"}},{"id":850804,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:36:53.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":5100,"price":3.3096,"value":16878.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":44579,"source":{"system":"sec-edgar","filing":"0001995275-26-000002","document":"form4-03102026_110350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000002/form4-03102026_110350.xml","form_type":"4"}},{"id":850803,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:36:53.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":16250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."}],"balance_after":49679,"source":{"system":"sec-edgar","filing":"0001995275-26-000002","document":"form4-03102026_110350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000199527526000002/form4-03102026_110350.xml","form_type":"4"}},{"id":1179311,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-03T23:22:11.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":775828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":775828,"derivative":{"underlying":"Common Stock","underlying_shares":775828},"source":{"system":"sec-edgar","filing":"0001415889-25-010076","document":"form4-04032025_110406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925010076/form4-04032025_110406.xml","form_type":"4"}},{"id":1179310,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T23:22:11.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":775828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":775828,"derivative":{"exercise_price":1.7,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":775828},"source":{"system":"sec-edgar","filing":"0001415889-25-010076","document":"form4-04032025_110406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925010076/form4-04032025_110406.xml","form_type":"4"}},{"id":1235598,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T01:37:50.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":48750,"derivative":{"underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001415889-25-006316","document":"form4-03042025_010346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006316/form4-03042025_010346.xml","form_type":"4"}},{"id":1235597,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T01:37:50.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":5690,"price":2.35,"value":13371.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":33429,"source":{"system":"sec-edgar","filing":"0001415889-25-006316","document":"form4-03042025_010346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006316/form4-03042025_010346.xml","form_type":"4"}},{"id":1235596,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T01:37:50.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":16250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."}],"balance_after":39119,"source":{"system":"sec-edgar","filing":"0001415889-25-006316","document":"form4-03042025_010346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006316/form4-03042025_010346.xml","form_type":"4"}},{"id":1391756,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-10-03T23:03:40.000Z","date":"2024-10-02","kind":"exercise","planned":false,"acquired":false,"shares":32558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32558},"source":{"system":"sec-edgar","filing":"0001415889-24-024676","document":"form4-10032024_111036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924024676/form4-10032024_111036.xml","form_type":"4"}},{"id":1391755,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T23:03:40.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":9689,"price":1.94,"value":18796.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":22869,"source":{"system":"sec-edgar","filing":"0001415889-24-024676","document":"form4-10032024_111036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924024676/form4-10032024_111036.xml","form_type":"4"}},{"id":1391754,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T23:03:40.000Z","date":"2024-10-02","kind":"exercise","planned":false,"acquired":true,"shares":32558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."}],"balance_after":32558,"source":{"system":"sec-edgar","filing":"0001415889-24-024676","document":"form4-10032024_111036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924024676/form4-10032024_111036.xml","form_type":"4"}},{"id":1602816,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T00:15:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter.  \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter.  \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":65000,"derivative":{"underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001415889-24-006414","document":"form4-03052024_120318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924006414/form4-03052024_120318.xml","form_type":"4"}},{"id":1602815,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T00:15:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":130000,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-24-006414","document":"form4-03052024_120318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924006414/form4-03052024_120318.xml","form_type":"4"}},{"id":1602814,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2024-03-05T00:15:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":30768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date.  \"Grant Date\" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance."}],"balance_after":30768,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":30768},"source":{"system":"sec-edgar","filing":"0001415889-24-006414","document":"form4-03052024_120318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924006414/form4-03052024_120318.xml","form_type":"4"}},{"id":1767194,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T22:49:33.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":490000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2023 Inducement Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest one (1) year after the Date of Grant, and one-forty-eighth (1/48th) of the shares subject to the option shall vest monthly thereafter on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable four (4) years from the Date of Grant.  \"Date of Grant\" shall mean October 2, 2023."}],"balance_after":490000,"derivative":{"exercise_price":0,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":490000},"source":{"system":"sec-edgar","filing":"0001209191-23-051695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919123051695/doc4.xml","form_type":"4"}},{"id":1767193,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46411,"kind":"person","name":"Lennon David James","position":1,"cik":"0001995275","reported_name":"Lennon David James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-03T22:49:33.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":32558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024."}],"balance_after":32558,"derivative":{"underlying":"Common Stock","underlying_shares":32558},"source":{"system":"sec-edgar","filing":"0001209191-23-051695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919123051695/doc4.xml","form_type":"4"}}]}